web analytics
25 C
Munich
Thursday, August 11, 2022

Cryomass Technologies Inc (OTCMKTS: CRYM) on the Move as Co Completes Testing of CryoCann 500 CF & Prepares to Deliver First Commercial Unit

Cryomass Technologies Inc (OTCMKTS: CRYM) has been making an explosive move up the charts in recent trading after the Company reported rigorous testing of its patented cryogenic trichrome separation system has yielded results in all key areas of interest that either met or significantly surpassed pre-testing expectations.  The Company is now busily preparing to deliver its first commercial unit to an operating partner based in the heart of the largest cannabis production region of the world’s largest cannabis market, California. This Monterey-based company manufactures premium extracts for their own brand and several of the more prominent, better-known brands in California.  Their extensive expertise in producing high-quality, standardized extracts should prove invaluable as we refine standard operating procedures (SOP) to guide product development for future customers. CRYM is establishing a toll processing station at their sophisticated Monterey facility, where the Company expects to process cannabis on behalf of some of California’s leading cannabis cultivators, many of which are already close business relationships.  CRYM is confident this partnership will begin generating revenues in the 4th quarter of 2022 and anticipate a steep ramp-up in revenues throughout 2023. 

CRYM has a long history of making big moves off its $0.20 base including running to hit a high of $0.64 last year followed by several months of choppy waters, another test of $0.20 support and a recent runup to $0.54. Now that CRYM is once again on the move surpassing $0.30 on Friday investors are quickly catching on to this story. CRYM trades at a very reasonable market valuation with OS at  201,478,332 and 88,737,648 shares in the float. CRYM is a sec filer and fully reporting OTCQB venture exchange Company that recently completed a $10.3 million equity financing. The Company has a strong balance sheet with $3,667,453, just $1.5 million in debt and $13,326,693 in total assets.  

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Cryomass Technologies Inc (OTCMKTS: CRYM) owner of superior, patented technology is building out its industry shattering CryoCann 500 CF for the handling of harvested cannabis, hemp and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value materials and essential compounds from the harvested plant. Building on that technology, the company’s technical team has completed an initial design for the CryoCann 500 CF system. The CryoCann 500 CF is optimized for the rapid capture (within minutes after plant harvesting) of fully intact cannabis and hemp trichomes, as well as terpenes. Rapid capture should enable cannabis and hemp producers to dramatically reduce costs, increase end-product yields and enhance product purity. The resulting sift can be warehoused for extended periods, or further processed into consumer products. The company believes that efficiencies delivered by the CryoCann 500 CF will trigger industry-wide changes in the handling and processing of harvested cannabis and hemp. It also is exploring the application of the underlying technology to a broad range of industries that handle high-value materials that could benefit from precision capture methods. 

CryoMass Technologies | Refinement Systems for Cannabis and HempThe CryoMass Refinement System uses patented technology to instantly freeze the whole plant and fully separates the trichomes, including THC, CBD and terpenes, from the biomass. The patented process renders up to a 90% dried output material with a dramatic reduction in biomass volume of up to 80%. The resulting high purity, refined “cryogenic sift” can be warehoused for extended periods of time or further processed into cannabis and hemp distillate or isolate for use in consumer products. 

Recently CRYM was granted a patent by the Canadian Intellectual Property Office (#3064896) for its novel plant material separation process technology.  The patent relates in general to separating plant particulates and, in particular, to a system and method for cryogenic separation of plant material.  The patent will remain valid until 2039. The Canadian patent follows the precedent set by the United States Patent and Trademark Office and the State Intellectual Property Office of the P. R. of China, both of which granted process patents to CryoMass that are valid until 2038. CryoMass remains committed to expanding its global patent protection portfolio and is pursuing patents in other important jurisdictions, including the European Union. 

To Find out the inside Scoop on CRYM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

CRYM

On August 4 CRYM announced rigorous testing of its patented cryogenic trichrome separation system has yielded results in all key areas of interest that either met or significantly surpassed pre-testing expectations.  The Company is now busily preparing to deliver its first commercial unit to an operating partner based in the heart of the largest cannabis production region of the world’s largest cannabis market, California. This Monterey-based company manufactures premium extracts for their own brand and several of the more prominent, better-known brands in California.  Their extensive expertise in producing high-quality, standardized extracts should prove invaluable as we refine standard operating procedures (SOP) to guide product development for future customers. CRYM is establishing a toll processing station at their sophisticated Monterey facility, where the Company expects to process cannabis on behalf of some of California’s leading cannabis cultivators, many of which are already close business relationships.  CRYM is confident this partnership will begin generating revenues in the 4th quarter of 2022 and anticipate a steep ramp-up in revenues throughout 2023. 

CryoMass Technologies | Refinement Systems for Cannabis and HempThe CryoMass system enables cannabis and hemp cultivators and processors to optimize and streamline their processes, thus dramatically reducing costs while simultaneously capturing approximately 97% of the active elements and increasing the purity and quality of the products sold to consumers. 

CryoMass Director and CEO Christian Noël stated, “Finally, after seven years of engineering, product development, and testing, we are ready to commercialize this exciting new technology.  And the demand is incredible.  Every week we receive inquiries from cannabis and hemp cultivators and processors from all around the United States and the rest of the world as well.  It’s an exciting time for us. Our initial target market is North America, especially the United States.  We think our first deployment in Monterey will serve to attract cultivators from within a four-hour radius seeking to avail themselves of this “must-have” new cryogenic trichome separation technology.  Between Santa Barbara and Monterey, we will be positioned to toll-process for approximately 5,000 cultivation licenses representing 60% of the entire California market.  We view this first installation as the perfect venue to showcase the CryoMass system to future customers from all around the globe.” 

It is important to note that one of the key reasons the CryoMass system is so much more efficient from a process and cost-saving perspective is that it is the only continuous-feed separation system while all others are batch-feed systems. Although the Company’s initial focus is on the cannabis and hemp sector, there is tremendous potential to generate important revenue streams from processing other high-value, trichrome-rich plants where similar cost savings and end-product improvements can be realized. 

For More on CRYM Subscribe Right Now!

Currently trading at a $59 million market cap CRYM has 200,435,331 shares outstanding 114,173,042 of which are restricted with just 88,737,648 shares in the float. CRYM is a sec filer and fully reporting OTCQB venture exchange Company that recently completed a $10.3 million equity financing. The Company has a strong balance sheet with $3,667,453, just $1.5 million in debt and $13,326,690 in total assets. CRYM recently completed rigorous testing of its patented cryogenic trichrome separation system has yielded results in all key areas of interest that either met or significantly surpassed pre-testing expectations.  The Company is now busily preparing to deliver its first commercial unit to an operating partner based in the heart of the largest cannabis production region of the world’s largest cannabis market, California. This Monterey-based company manufactures premium extracts for their own brand and several of the more prominent, better-known brands in California.  Their extensive expertise in producing high-quality, standardized extracts should prove invaluable as we refine standard operating procedures (SOP) to guide product development for future customers. CRYM is establishing a toll processing station at their sophisticated Monterey facility, where the Company expects to process cannabis on behalf of some of California’s leading cannabis cultivators, many of which are already close business relationships.  CRYM is confident this partnership will begin generating revenues in the 4th quarter of 2022 and anticipate a steep ramp-up in revenues throughout 2023.  We will be updating on CRYM when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CRYM.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in CRYM either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.